Characterizing emerging molecular targets in ovarian cancer within standard therapeutic frameworks
Ovarian cancer remains one of the most lethal gynecological malignancies, with high mortality rates largely due to late-stage diagnosis and resistance to conventional therapies. Recent advances in molecular biology have identified several novel targets that offer potential for more effective and personalized treatment strategies. However, integrating these emerging molecular targets within existing therapeutic frameworks poses significant challenges and opportunities. This research aims to bridge this gap by thoroughly characterizing these new targets and evaluating their compatibility and effectiveness within current treatment paradigms.
Objectives:
-
Identify and Analyze Emerging Molecular Targets:
- Conduct a comprehensive review and experimental analysis to identify and validate novel molecular targets associated with ovarian cancer progression in various models.
-
Evaluate Therapeutic Potential:
- Assess the therapeutic potential of these emerging targets through preclinical studies.
-
Integrate Within Standard Therapeutic Frameworks:
- Develop strategies to explore these molecular targets into existing treatment protocols.
The minimum diploma level of the candidate needs to be
- Academic bachelor
The candidate needs to have a background in
- Biology
- Medical